Pressure BioSciences Competitors and Similar CompaniesClear all

Pressure BioSciences's competitors and similar companies include Otto Bock HealthCare, ZimVie, Smith & Nephew and Terumo Medical.

	Pressure BioSciences Pressure bioscience is focused on developing, marketing and selling proprietary laboratory instrumentation and associated consumables.	Otto Bock HealthCare Otto Bock HealthCare is a med tech company.	ZimVie ZimVie is a company that produces dental, spine, and bone healing products.	Smith & Nephew Smith & Nephew is a medical technology company.	Terumo Medical Terumo Medical is a company that develops medical devices.
Founding Date	Founding Date 2004	Founding Date 1919	Founding Date 2022	Founding Date 1856	Founding Date 1972
Type	Type Public	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare healthtech medical devices medtech	Tags Healthcare medical devices medtech
Locations	Locations Easton, US HQ Medford, US	Locations Duderstadt, DE HQ Ouled Fayet, DZ Buenos Aires, AR Baulkham Hills, AU Wien, AT Sarajevo, BA see more	Locations Westminster, US HQ Macquarie Park, AU Wien, AT Mechelen, BE Sao Paulo, BR Mississauga, CA Santiago, CL see more	Locations Watford, GB HQ Buenos Aires, AR Macquarie Park, AU Schwechat, AT Zaventem, BE São Paolo, BR Mississauga, CA see more	Locations Somerset, US HQ Sao Paulo, BR Vaughan, CA Hangzhou, CN Ciudad De México, MX Breinigsville, US Elkton, US see more
Employees	Employees 1721% increase	Employees 3,893	Employees 2,700	Employees 17,349	Employees 2,7491% increase
Valuation ($)	Valuation ($) 560.7 k	Valuation ($) N/A	Valuation ($) 377.5 m	Valuation ($) 13.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $2m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $449.7m (FY, 2024)	Revenue (est.) $6.2b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $1.2m (FY, 2023)	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $799.6k (FY, 2023)	Gross profit N/A	Gross profit N/A	Gross profit $4.8b (FY, 2025)	Gross profit N/A
Net income	Net income ($29.3m) (FY, 2023)	Net income N/A	Net income ($25.8m) (FY, 2024)	Net income $625m (FY, 2025)	Net income N/A